Newsroom

Sorted by: Latest

-

Northwell to Launch Long Island’s First Pancreas Transplant Program

MANHASSET, N.Y.--(BUSINESS WIRE)--Northwell Health has received approval to launch Long Island’s first adult pancreas transplant program, according to a letter from the New York State Department of Health (DOH). The Northwell Transplant Institute at North Shore University Hospital (NSUH) recently hosted a site visit with DOH officials, the final hurdle before opening the program to new patients. Northwell’s pancreas program will open access to patients across the greater New York and southern C...
-

Securities Fraud Investigation Into Charming Medical Limited (MCTA) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of Charming Medical Limited (“Charming” or the “Company”) (NASDAQ: MCTA) on behalf of investors concerning the Company’s possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON CHARMING MEDICAL LIMITED (MCTA), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING A CLAIM TO RECOVER YOUR LOSS. What Is The Investigation About? On November 11, 2025, after market hours, the SEC issu...
-

SABA Announces $0.10 Special Dividend

NEW YORK--(BUSINESS WIRE)--Saba Capital Income & Opportunities Fund II (NYSE: SABA) (the “Fund”), a registered closed-end management investment company listed on the New York Stock Exchange, declared a special dividend of $0.10 per share on December 22, 2025, payable on January 16, 2026 to shareholders of record as of December 31, 2025. Special Dividend. The above special distribution was declared in order to satisfy certain requirements prescribed by excise tax rules applicable to certain...
-

Samsung Bioepis Announces Approval of Ustekinumab Biosimilar in Japan

INCHEON, Korea--(BUSINESS WIRE)--Samsung Bioepis Co., Ltd. today announced the marketing approval of Ustekinumab BS Subcutaneous Injection 45mg Syringes 'NIPRO', a biosimilar referencing Stelara1 (ustekinumab), developed by Samsung Bioepis. This is the first product to gain marketing approval in Japan under the partnership with NIPRO CORPORATION entered in June 2025. “Japan allocates about 10% of its GDP to healthcare2, one of the highest among OECD countries which is why biosimilars are playin...
-

FFIV ALERT: Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of F5, Inc. Investors

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf of investors who acquired F5, Inc. (“F5” or the “Company”) (NASDAQ:FFIV) securities during the period of October 28, 2024 through October 27, 2025, inclusive (“the Class Period”). If you suffered a loss on your F5 investments, you have until February 17, 2026 to request lead plaintiff appointment. For more information: [CONTACT THE FIRM IF YOU SUFFERED A LOSS] What Is Th...
-

Walker & Dunlop Arranges Sale and Financing for Cambridge Multifamily Asset

BETHESDA, Md.--(BUSINESS WIRE)--Walker & Dunlop Capital Markets announced today that it arranged the sale and financing of 929 MASS, a mixed-use, two-building property located in the heart of Cambridge, in Central Square, Massachusetts. Travis D’Amato, Michael Coyne, Brendan Shields, Kevin Gleason, and Maggie McFarland, executed the $53.6 million sale of the property on behalf of an institutional seller. Concurrently, Andrew Gnazzo and Mike Darling secured acquisition financing for John M C...
-

Harvest ETFs Announces Revised Estimated Annual 2025 Reinvested Harvest High Income Shares ETFs Distributions

OAKVILLE, Ontario--(BUSINESS WIRE)--Harvest Portfolios Group Inc. (“Harvest”) announces the estimated annual reinvested distributions for Harvest High Income Shares ETFs TM that are exchange traded mutual fund trusts for the 2025 tax year. Harvest High Income Shares ETFs TM that are a class of a mutual fund corporation will report separately. Please be advised that the estimated distributions announced in this press release replace those stated in the November 28, 2025 press release for the Har...
-

FNB Harvest annonce Distributions réinvesties annuelles estimées révisées pour les FNB Harvest d'actions à revenu élevé pour 2025

OAKVILLE, Ontario--(BUSINESS WIRE)--Groupe de portefeuilles Harvest Inc. (« Harvest ») annonce les distributions réinvesties annuelles estimées pour les FNB Harvest actions à revenu élevé MC pour l'année d'imposition 2025. FNB Harvest actions à revenu élevé MC qui constituent une catégorie d'une société de fonds communs de placement feront l'objet de rapports distincts. Veuillez noter que les distributions estimées annoncées dans ce communiqué de presse remplacent celles indiquées dans le commu...
-

Green Oceans Applauds Trump Administration for Suspending Offshore Wind Leases to Protect National Security and American Interests

WASHINGTON--(BUSINESS WIRE)--Green Oceans applauds the Trump Administration for making a landmark decision to suspend all large-scale offshore wind projects, prioritizing national security. “By President Trump and Secretary Burgum prioritizing national security over a faulty energy program, the Administration reinforces its stance that safeguarding the nation remains paramount,” said Lisa Knight, president, Green Oceans. She continues, “This action reflects a proactive approach to mitigating se...
-

FCPT Announces Acquisition of a National Veterinary Associates Property for $4.4 Million

MILL VALLEY, Calif.--(BUSINESS WIRE)--Four Corners Property Trust (NYSE:FCPT), a real estate investment trust primarily engaged in the ownership and acquisition of high-quality, net-leased restaurant and retail properties (“FCPT” or the “Company”), is pleased to announce the acquisition of a National Veterinary Associates property for $4.4 million. The property is newly constructed and located in a highly trafficked corridor in Georgia and is corporate-operated, under a long term, net lease wit...